B-cell malignancies
HealthStudy finds low-dose CAR T therapy can drive complete cancer remission
A first-in-human trial suggests stem-like CAR T cells may expand longer and work better at lower doses.
Joseph Shavit
A first-in-human trial suggests stem-like CAR T cells may expand longer and work better at lower doses.
Joseph Shavit